Skip to main content
OpenTrials
Completed

NCT Number: NCT03458026

Move Your Spondyl " Better Live Its Rheumatism With the Physical Activity "

By this project, the investigators are going to try to demonstrate that to use objects connected to make a physical activity can have an impact on the clinical activity of the disease by bringing the subjects which present a spondyloarthritis to make a physical activity. The investigators shall show furthermore, than the use of connected objects also has better chances to glue the patients presenting a spondyloarthritis to a practice of regular physical activity that a simple recommendation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Spondyloarthritis Arthritis Behavior Bone Diseases Joint Diseases Motor Activity Musculoskeletal Diseases Spinal Diseases Spondylarthritis Spondylitis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de Nice

Nice, France, 06003

About this study

This project is aimed at subjects with Axial Spondyloarthritis and / or peripheral of the Alpes Maritimes and more specifically of the city of Nice and its surroundings. The subjects will be recruited by the hospital doctors (consultations, hospitalization). Patients will benefit from an inclusion visit in order to explain the protocol, sign the study consent and eliminate a possible contraindication to physical activity. Knowing that this is a physical activity adapted to the health of people and their physical abilities.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presenting a spondyloarthritis according to the criteria of the ASAS (l'Assessment of SpondyloArthritis international Society)
  • Benefiting from a stable treatment by biotherapies for at least 3 months

Exclusion criteria

  • Patient presenting a cardiac pathology should be decompensating
  • Patients having a contraindication in the physical activity
  • Lung affection making impossible the effort
  • Patient already realizing a physical activity supervised in club or with sports coach

Treatment and study plan

Connected object use combined with SMS (text messages) of physical activity reminders

Other

Watch connected used and receipt of SMS (text messages)

Without connected object

Other

Any intervention except follow-up visit

Primary outcomes

  1. Number of pushes brought reported by the patient through a filled auto-questionnaire every week

    Time frame: After 12 weeks

    This questionnaire containing 3 items: did you present a push of your disease since the last filling of the questionnaire?,not, yes during 1 in 3 in the daytime,yes more than 3 days

Secondary outcomes

  1. Moderators of the membership will be estimated thanks to the EMAPS (Scale of Motivation for Physical activity for health purposes) and thanks to the Big five

    Time frame: 12 weeks

    the EMAPS questionnaire will allow to quantify by the motivation of the patients to practice a physical activity.

    this questionnaire is specifically for health purposes.

  2. The level of commitment in the physical activity will be estimated by the questionnaire GPAQ (Global Physical Activity Questionnaire)

    Time frame: 12 weeks

    the qestionnaire GPAQ is a scale to quantify overall physical activity (based on physical activity at work and in the home).

  3. The function will be estimated by the BASFI (Bath Ankylosing Spondylitis Fonctional Index)

    Time frame: 12 weeks

  4. The activity of the disease will be estimated by the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index)

    Time frame: 12 weeks

  5. The activity of the disease will be estimated by the BASFI (Bath Ankylosing Spondylitis Fonctional Index)

    Time frame: 12 weeks

  6. The activity of the disease will be estimated by the ASQOL (Ankylosing Spondylitis Quality of Life Questionnaire)

    Time frame: 12 weeks

    the ASQOL questionnaire is a quality of life scale. this questionnaire is specifically designed for patients with spondyloarthritis.

  7. The activity of the disease will be estimated by the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index)

    Time frame: 24 weeks

  8. The activity of the disease will be estimated by the BASFI (Bath Ankylosing Spondylitis Fonctional Index)

    Time frame: 24 weeks

  9. The activity of the disease will be estimated by the ASQOL (Ankylosing Spondylitis Quality of Life Questionnaire)

    Time frame: 24 weeks

    the ASQOL questionnaire is a quality of life scale. this questionnaire is specifically designed for patients with spondyloarthritis.

  10. The activity of the disease will be estimated by the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index)

    Time frame: 36 weeks

  11. The activity of the disease will be estimated by the BASFI (Bath Ankylosing Spondylitis Fonctional Index)

    Time frame: 36 weeks

  12. The activity of the disease will be estimated by the ASQOL (Ankylosing Spondylitis Quality of Life Questionnaire)

    Time frame: 36 weeks

    the ASQOL questionnaire is a quality of life scale. this questionnaire is specifically designed for patients with spondyloarthritis.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Collaborators

  • Azur sante
  • LAMHNESS

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Mar 8, 2018
Registry last updated
Mar 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.